Added to YB: 2025-02-10
Pitch date: 2025-02-08
VYT.MC [bullish]
Vytrus Biotech, S.A.
+641.67%
current return
Author Info
Thibault is a small investor in SME with an interest in Macro trends. Sign up for the newsletter.
Company Info
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally.
Market Cap
EUR 133.8M
Pitch Price
EUR 2.40
Price Target
4.70 (-74%)
Dividend
N/A
EV/EBITDA
38.79
P/E
46.19
EV/Sales
13.58
Sector
Personal Care Products
Category
growth
Vytrus Biotech - A spanish nano cap
VYT.MC: Plant stem cell biotech for cosmetics. 30%+ revenue growth, leveraging existing infrastructure. Q3 2024 strong: revenue +36%, EBITDA +83%. 2027 targets: €12M revenue, €5M EBITDA, €2.5M net. Trading at 18x P/E, 100%+ upside potential. Risks: small cap, Spain-based.
Read full article (6 min)